Based on the Medincell SA stock forecast from 0 analysts, the average analyst target price for Medincell SA is not available over the next 12 months. Medincell SA’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Medincell SA is Slightly Bearish, which is based on 3 positive signals and 4 negative signals. At the last closing, Medincell SA’s stock price was EUR 16.80. Medincell SA’s stock price has changed by +3.07% over the past week, -2.33% over the past month and +151.12% over the last year.
No recent analyst target price found for Medincell SA
No recent average analyst rating found for Medincell SA
Company Overview Medincell SA
MedinCell S.A., a pharmaceutical company, develops long acting injectables in various therapeutic areas in France. It develops solutions based on BEPO, a long-acting injectable technology; and offers UZEDY (mdc-IRM) for the treatment of schizophrenia in adults. The company's products in development include mdc-CWM, a sustained-release formulation of celecoxib in Phase III trials for use in the treatment of reduction of postoperative pain and inflammation; and mdc-TJK, a subcutaneous injection that is in Phase III clinical trials for use in the treatment of schizophrenia. Its product candidates in preclinical trials include mdc-WWM for contraception; and mdc-STM for malaria. MedinCell S.A. was incorporated in 2003 and is headquartered in Jacou, France. Read Less
MedinCell S.A., a pharmaceutical company, develops long acting injectables in various therapeutic areas in France. It develops solutions based on BEPO, a long-acting injectable technology; and offers UZEDY (mdc-IRM) for the treatment of schizophrenia in adults. The company's prod...Read More
Frequently Asked Questions About Medincell SA (MEDCL:PA) Stock
Stock Target Advisor's fundamental analysis for Medincell SA's stock is Slightly Bearish.
Unfortunately we do not have enough data on MEDCL:PA's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on MEDCL:PA's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on MEDCL:PA's stock to indicate if its overvalued.
The last closing price of MEDCL:PA's stock was EUR 16.80.
The most recent market capitalization for MEDCL:PA is EUR 0.54B.
Unfortunately we do not have enough analyst data on MEDCL:PA's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Medincell SA's stock.
As per our most recent records Medincell SA has 134 Employees.
Medincell SA's registered address is 3 rue des FrEres LumiEre, Jacou, France, 34830.
You can get more information about it from Medincell SA's website at https://www.medincell.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
High Gross Profit to Asset Ratio
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Frequently Asked Questions About Medincell SA (MEDCL:PA) Stock
Stock Target Advisor's fundamental analysis for Medincell SA's stock is Slightly Bearish.
Unfortunately we do not have enough data on MEDCL:PA's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on MEDCL:PA's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on MEDCL:PA's stock to indicate if its overvalued.
The last closing price of MEDCL:PA's stock was EUR 16.80.
The most recent market capitalization for MEDCL:PA is EUR 0.54B.
Unfortunately we do not have enough analyst data on MEDCL:PA's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Medincell SA's stock.
As per our most recent records Medincell SA has 134 Employees.
Medincell SA's registered address is 3 rue des FrEres LumiEre, Jacou, France, 34830.
You can get more information about it from Medincell SA's website at https://www.medincell.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for MEDCL:PA !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
